Stockreport

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Executed Term Sheet from an institutional investor for an initial $7.5 million note, subject to common closing requirements, primarily to replace current debt, clearing [Read more]